VIMSELTINIB vs VINORELBINE: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
VIMSELTINIB vs VINORELBINE: Safety Overview
| Metric | VIMSELTINIB | VINORELBINE |
|---|---|---|
| Total FAERS Reports | 170 | 5,176 |
| Deaths Reported | 0 | 840 |
| Death Rate | N/A | 16.2% |
| Hospitalizations | 5 | 1,790 |
| Average Patient Age | 45.6 yrs | 54.8 yrs |
| % Female Patients | 55.4% | 71.8% |
| FDA Approval Date | Feb 14, 2025 | Apr 18, 2005 |
| Manufacturer | Deciphera Pharmaceuticals, LLC | Sagent Pharmaceuticals |
| Route | ORAL | INTRAVENOUS |
| Marketing Status | Prescription | Discontinued |